These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Kawasaki syndrome in adults: treatment with polyvalent intravenous immunoglobulins]. Pavese P; Brion JP; Meusnier T; Stahl JP Ann Med Interne (Paris); 1997; 148(3):287-8. PubMed ID: 9255342 [No Abstract] [Full Text] [Related]
25. What do we know about Kawasaki disease? Kucińska B; Wróblewska-Kałuzewska M Med Sci Monit; 2000; 6(6):1227-31. PubMed ID: 11208484 [TBL] [Abstract][Full Text] [Related]
26. [Immunoglobulin in suspected Kawasaki disease]. García Soblechero E; Gómez Santos E; Domínguez Quintero ML; González Vila L An Pediatr (Barc); 2010 Sep; 73(3):151-2. PubMed ID: 20605119 [No Abstract] [Full Text] [Related]
27. Three episodes of Kawasaki disease including one after the Pneumo 23 vaccine in a child with a family history of Kawasaki disease. Kraszewska-Głomba B; Kuchar E; Szenborn L J Formos Med Assoc; 2016 Oct; 115(10):885-886. PubMed ID: 27364880 [No Abstract] [Full Text] [Related]
28. Resistant Kawasaki disease. Nachiappan J; May M; Hawker RE; Hong P J Paediatr Child Health; 2004; 40(9-10):576-8. PubMed ID: 15367156 [No Abstract] [Full Text] [Related]
30. Infliximab for the treatment of Kawasaki disease. Matsubara T Pediatr Int; 2018 Sep; 60(9):775. PubMed ID: 30255976 [No Abstract] [Full Text] [Related]
31. Lessons from Kawasaki disease: all brands of IVIG are not equal. Stiehm ER J Pediatr; 2006 Jan; 148(1):6-8. PubMed ID: 16423589 [No Abstract] [Full Text] [Related]
32. [IVIG-steroids combination therapy for initial treatment of Kawasaki disease]. Yoshikane Y; Hirose S Nihon Rinsho; 2016 Aug; 74 Suppl 6():522-6. PubMed ID: 30547554 [No Abstract] [Full Text] [Related]
33. Arthritis in Kawasaki disease after responding to intravenous immunoglobulin treatment. Lee KY; Oh JH; Han JW; Lee JS; Lee BC Eur J Pediatr; 2005 Jul; 164(7):451-2. PubMed ID: 15782294 [No Abstract] [Full Text] [Related]
34. Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation. Pagnini I; Marino A; Simonini G; Cimaz R Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S170. PubMed ID: 22410254 [No Abstract] [Full Text] [Related]
35. Kawasaki disease in an 18-month-old boy. Wróblewska-Kałuzewska M; Kucińska B; Werner B Med Sci Monit; 2000; 6(6):1170-3. PubMed ID: 11208475 [TBL] [Abstract][Full Text] [Related]
36. [Current state of diagnosis and treatment of incomplete Kawasaki disease]. Zhang QY; Du JB Zhonghua Er Ke Za Zhi; 2006 May; 44(5):339-41. PubMed ID: 16780709 [No Abstract] [Full Text] [Related]
37. Uncovering a Unique Cause of Parotitis in an Adolescent. Alcamo AM; Astudillo CL; Gray SB; Klein M Clin Pediatr (Phila); 2016 Aug; 55(9):880-2. PubMed ID: 26324663 [No Abstract] [Full Text] [Related]
38. Kawasaki disease with predominant central nervous system involvement. Tabarki B; Mahdhaoui A; Selmi H; Yacoub M; Essoussi AS Pediatr Neurol; 2001 Sep; 25(3):239-41. PubMed ID: 11587880 [TBL] [Abstract][Full Text] [Related]
39. [Kawasaki syndrome: review of the literature and presentation of 4 clinical cases]. De Martino MP; Grenci G; Costantino D; Mammì F; Stilo L; Costantino G Pediatr Med Chir; 1994; 16(1):63-7. PubMed ID: 8029092 [TBL] [Abstract][Full Text] [Related]
40. Response of refractory Kawasaki disease to intravenous methylprednisolone. Shah I; Prabhu SS Ann Trop Paediatr; 2009 Mar; 29(1):51-3. PubMed ID: 19222935 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]